Issued Patents 2023
Showing 1–22 of 22 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11779633 | Glucagon-like peptide 1 receptor agonists and uses thereof | Yang Wei, Haruka Okamoto, Jesper Gromada, Samuel Davis | 2023-10-10 |
| 11778995 | Genetically modified non-human animals and methods of use thereof | Richard Flavell, Till Strowig, Markus Manz, Chiara Borsotti, Madhav Dhodapkar +2 more | 2023-10-10 |
| 11767358 | Human antibodies to Bet v 1 and methods of use thereof | Jamie M. Orengo, Ashok T. Badithe, Vishal Kamat, Yashu Liu | 2023-09-26 |
| 11766032 | Genetically modified non-human animals expressing human EPO | Sean Stevens, Richard Flavell, Markus Manz, Liang Shan | 2023-09-26 |
| 11760775 | Steroids and protein-conjugates thereof | Amy Han, William Olson | 2023-09-19 |
| 11732030 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Robert Babb, Alina BAUM, Gang Chen, Cindy Gerson, Johanna Hansen +7 more | 2023-08-22 |
| 11708407 | Antigen binding molecule formats | Tong Zhang, Erica Pyles, Michael Rosconi, Nina Liu, Supriya Patel +3 more | 2023-07-25 |
| 11697828 | Methods and compositions for targeted genetic modification using paired guide RNAs | David Frendewey, Ka-Man Venus Lai, Wojtek Auerbach, Gustavo Droguett, Anthony Gagliardi +4 more | 2023-07-11 |
| 11684050 | Non-human animals having a humanized programmed cell death 1 gene | Elena Burova, Alexander O. Mujica, Ka-Man Venus Lai | 2023-06-27 |
| 11666040 | Humanized non-human animals with restricted immunoglobulin heavy chain loci | Lynn Macdonald, Sean Stevens, Margaret Karow, John McWhirter | 2023-06-06 |
| 11642390 | Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody | Panayiotis Stevis, Jesper Gromada, Yonaton Ray, Jee H. Kim, Ivan B. Lobov | 2023-05-09 |
| 11629195 | Anti-IL2 receptor gamma antigen-binding proteins | Jamie M. Orengo | 2023-04-18 |
| 11617357 | Humanized light chain mice | Lynn Macdonald, Cagan Gurer, Karolina A. Hosiawa, Sean Stevens | 2023-04-04 |
| 11612151 | Humanized light chain mice | Lynn Macdonald, Cagan Gurer, Karolina A. Hosiawa, Sean Stevens | 2023-03-28 |
| 11608381 | Methods of treatment using a leptin receptor agonist antibody | Jesper Gromada, Panayiotis Stevis, Judith Altarejos | 2023-03-21 |
| 11589562 | Mouse model of DITRA disease and uses thereof | Alexander O. Mujica, Ka-Man Venus Lai, Sokol Haxhinasto | 2023-02-28 |
| 11576984 | Genetically modified mouse with humanized immunoglobulin heavy chain constant region genes and method of using | Vera Voronina, Corey Momont, John McWhirter, Naxin Tu, Lynn Macdonald | 2023-02-14 |
| 11578135 | Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof | Nicholas J. Papadopoulos, Aris N. Economides, Katherine Cygnar | 2023-02-14 |
| 11578127 | Anti-Fc epsilon-R1 alpha (FcεR1α) antibodies, bispecific antigen-binding molecules that bind FcεR1α and CD3, and uses thereof | Jamie M. Orengo, Andre Limnander, Jee H. Kim | 2023-02-14 |
| 11576356 | Genetically modified non-human animals and methods of use thereof | Dietmar Herndler-Brandstetter, Richard Flavell, Davor Frleta, Cagan Gurer, Markus Manz +6 more | 2023-02-14 |
| 11559050 | Humanized non-human animals with restricted immunoglobulin heavy chain loci | Lynn Macdonald, Sean Stevens, Margaret Karow, John McWhirter | 2023-01-24 |
| 11548947 | Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof | Dimitris Skokos, Janelle Waite, Erica Ullman, Aynur Hermann, Eric Smith +2 more | 2023-01-10 |